Lineage Cell Therapeutics Inc. (LCTX)
Market Closed
17 Jul, 15:25
TASE 
375. 60
ILA -0.2
-0.0532%
- Market Cap
- P/E Ratio
- Div Yield
4 Volume
-0.11 Eps
375.8 ILA
Previous Close Want to track LCTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lineage Cell Therapeutics Inc. (LCTX) Statistics
Valuation metrics
Market Cap -
Enterprise value 255.64M
Trailing P/E (ttm) -4.2
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 19.57
Price/Book (mrq) 5.28
Enterprise Value/Revenue 17.3
Enterprise Value/EBITDA -5.93
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.91K
Average volume (90 days) 4.86K
Price summary
52-Week low 3.1
52-Week high 435
Beta -
50-Day moving average 376.96
200-Day moving average 465.08
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 31 Oct 1997
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.34%
Operating margin -2.55%
Operational effectiveness
Return on assets -0.59%
Return on equity -1.52%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.22
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 6.89%
Book value per share (mrq) 0.22
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
